BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23684504)

  • 1. Effect of treatment with atenolol on 5-year survival in cats with preclinical (asymptomatic) hypertrophic cardiomyopathy.
    Schober KE; Zientek J; Li X; Fuentes VL; Bonagura JD
    J Vet Cardiol; 2013 Jun; 15(2):93-104. PubMed ID: 23684504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atenolol in cats with subclinical hypertrophic cardiomyopathy: a double-blind, placebo-controlled, randomized clinical trial of effect on quality of life, activity, and cardiac biomarkers.
    Coleman AE; DeFrancesco TC; Griffiths EH; Lascelles BDX; Kleisch DJ; Atkins CE; Keene BW
    J Vet Cardiol; 2020 Aug; 30():77-91. PubMed ID: 32707333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atenolol on heart rate, arrhythmias, blood pressure, and dynamic left ventricular outflow tract obstruction in cats with subclinical hypertrophic cardiomyopathy.
    Jackson BL; Adin DB; Lehmkuhl LB
    J Vet Cardiol; 2015 Dec; 17 Suppl 1():S296-305. PubMed ID: 26776587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
    Jung SW; Kittleson MD
    J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-stage hypertrophic cardiomyopathy in a cat.
    White AJ
    Can Vet J; 2015 May; 56(5):509-11. PubMed ID: 25969586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of ivabradine on dynamic obstruction of the left ventricular outflow tract in cats with preclinical hypertrophic cardiomyopathy.
    Blass KA; Schober KE; Li X; Scansen BA; Bonagura JD
    J Vet Intern Med; 2014; 28(3):838-46. PubMed ID: 24597596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ivabradine on heart rate and left ventricular function in healthy cats and cats with hypertrophic cardiomyopathy.
    Riesen SC; Schober KE; Smith DN; Otoni CC; Li X; Bonagura JD
    Am J Vet Res; 2012 Feb; 73(2):202-12. PubMed ID: 22280379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atenolol and survival in cats with asymptomatic hypertrophic cardiomyopathy.
    Vet Rec; 2016 Aug; 179(7):176. PubMed ID: 27516563
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of atenolol on left atrial and left ventricular function in healthy cats and in cats with hypertrophic cardiomyopathy.
    Sugimoto K; Aoki T; Fujii Y
    J Vet Med Sci; 2020 May; 82(5):546-552. PubMed ID: 32188801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study.
    Fox PR; Keene BW; Lamb K; Schober KA; Chetboul V; Luis Fuentes V; Wess G; Payne JR; Hogan DF; Motsinger-Reif A; Häggström J; Trehiou-Sechi E; Fine-Ferreira DM; Nakamura RK; Lee PM; Singh MK; Ware WA; Abbott JA; Culshaw G; Riesen S; Borgarelli M; Lesser MB; Van Israël N; Côté E; Rush JE; Bulmer B; Santilli RA; Vollmar AC; Bossbaly MJ; Quick N; Bussadori C; Bright JM; Estrada AH; Ohad DG; Fernández-Del Palacio MJ; Lunney Brayley J; Schwartz DS; Bové CM; Gordon SG; Jung SW; Brambilla P; Moïse NS; Stauthammer CD; Stepien RL; Quintavalla C; Amberger C; Manczur F; Hung YW; Lobetti R; De Swarte M; Tamborini A; Mooney CT; Oyama MA; Komolov A; Fujii Y; Pariaut R; Uechi M; Tachika Ohara VY
    J Vet Intern Med; 2018 May; 32(3):930-943. PubMed ID: 29660848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate and arrhythmia frequency of normal cats compared to cats with asymptomatic hypertrophic cardiomyopathy.
    Jackson BL; Lehmkuhl LB; Adin DB
    J Vet Cardiol; 2014 Dec; 16(4):215-25. PubMed ID: 25465341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy.
    Oldach MS; Ueda Y; Ontiveros ES; Fousse SL; Visser LC; Stern JA
    BMC Vet Res; 2021 Feb; 17(1):89. PubMed ID: 33622315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.
    Sherrid MV; Barac I; McKenna WJ; Elliott PM; Dickie S; Chojnowska L; Casey S; Maron BJ
    J Am Coll Cardiol; 2005 Apr; 45(8):1251-8. PubMed ID: 15837258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of red blood cell distribution width in cats with hypertrophic cardiomyopathy.
    Stanzani G; Cowlam R; English K; Connolly DJ
    J Vet Cardiol; 2015 Dec; 17 Suppl 1():S233-43. PubMed ID: 26776582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of the effects of pimobendan on survival time in cats with hypertrophic cardiomyopathy and congestive heart failure.
    Reina-Doreste Y; Stern JA; Keene BW; Tou SP; Atkins CE; DeFrancesco TC; Ames MK; Hodge TE; Meurs KM
    J Am Vet Med Assoc; 2014 Sep; 245(5):534-9. PubMed ID: 25148095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hypertrophic cardiomyopathy in a cohort of British Shorthair cats in Denmark.
    Granström S; Godiksen MT; Christiansen M; Pipper CB; Willesen JL; Koch J
    J Vet Intern Med; 2011; 25(4):866-71. PubMed ID: 21736622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right ventricular involvement in feline hypertrophic cardiomyopathy.
    Schober KE; Savino SI; Yildiz V
    J Vet Cardiol; 2016 Dec; 18(4):297-309. PubMed ID: 27667689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype correlation between the cardiac myosin binding protein C mutation A31P and hypertrophic cardiomyopathy in a cohort of Maine Coon cats: a longitudinal study.
    Granström S; Godiksen MT; Christiansen M; Pipper CB; Martinussen T; Møgelvang R; Søgaard P; Willesen JL; Koch J
    J Vet Cardiol; 2015 Dec; 17 Suppl 1():S268-81. PubMed ID: 26776585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant defence and oxidative stress markers in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy: a pilot study.
    Michałek M; Tabiś A; Pasławska U; Noszczyk-Nowak A
    BMC Vet Res; 2020 Jan; 16(1):26. PubMed ID: 32000761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Layer-specific myocardial function in asymptomatic cats with obstructive hypertrophic cardiomyopathy assessed using 2-dimensional speckle-tracking echocardiography.
    Suzuki R; Mochizuki Y; Yoshimatsu H; Niina A; Teshima T; Matsumoto H; Koyama H
    J Vet Intern Med; 2019 Jan; 33(1):37-45. PubMed ID: 30499128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.